ACB
Fiscal year ends March Quarters are offset from the calendar — Q1 is Apr–Jun

Aurora Cannabis Inc. is a cannabis producer and distributor. The company operates through subsidiaries including Aurora Cannabis Enterprises Inc., Aurora Germany, Aurora Nordic, Whistler, and Reliva LLC. Its main products include medical and recreational cannabis, cannabis oils, and hemp-derived CBD products under the Reliva brand. The company serves customers in Canada, the United States, Germany, Italy, the United Kingdom, and Poland, supplying medical cannabis to pharmacies and hospitals, and retail CBD products to consumers. Notable partnerships include a former strategic investment in Choom Holdings Inc. and a terminated partnership with the Ultimate Fighting Championship. The company was incorporated in 2006 and changed its name to Aurora Cannabis Inc. in 2014.

Summarised from the annual information form, filed Sep 2021

Industry Specialty Chemicals Homepage auroramj.com
Sector Basic Materials IR page auroramj.com/investors
Tags
cannabis, cbd, medical cannabis, hemp, recreational cannabis, pharmaceuticals, Aurora Cannabis Inc., Aurora Cannabis Enterprises Inc., Aurora Germany, Aurora Nordic, Whistler, Reliva LLC, MedReleaf, CanniMed, Prairie Plant Systems Ltd., Anandia, ICC Labs Inc., Hempco Food and Fiber Inc., Choom Holdings Inc., Reliva, 280 Park ACI Holdings LLC, Aurora River
Press page —

Metrics

Valuation  
Market cap $ 229.896M
Market cap (USD) $ 229.896M
P/E -2.58
PEG —
P/BV 0.64
P/S 1.02
P/OCF -24.13
P/FCF -9.04
Dividend yield —
Turnover / mcap —
Returns  
ROE -24.3%
ROI -29.2%
ROIC -7.5%
Profit margin -42.4%
Growth  
Revenue growing No
Profits growing No
Revenue up 3y —
Revenue up 5y —
Earnings growth 3y (net profit CAGR) —
Quality  
Profitable No
Margin expanding No
Buying back stock No
Diluting (TTM) Yes
Debt/Equity —
Podcast bulls (TTM) Sign up
Podcast bears (TTM) Sign up
Podcast sentiment (TTM) Sign up
Podcast sentiment % (TTM) Sign up
News sentiment (TTM) 76
Quality score -75.0%
Insiders  
Buys, 1w Sign up
Buys, 1m Sign up
Buys, 1y Sign up
Sells, 1w Sign up
Sells, 1m Sign up
Sells, 1y Sign up

Sign up to see this company's insider trades

Figure FY 2026 FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 FY 2018
Revenue 320.593M 343.293M 270.281M — 221.339M 245.252M 278.906M 247.939M 55.196M
Net profit -135.964M 1.591M -69.326M — -1.718B -695.089M -3.31B -290.837M 71.936M
Free cash flow -36.056M 952K -85.342M — -142.051M -263.659M -692.958M -606.543M -218.612M

Figure FY 2026 FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 FY 2018
Share price 4.56 6.13 5.98 0.95 — — — — —
Price performance 12m -0.26 0 5.3 — — — — — —

Filed figures

Figure Jun 2018 Jun 2019 Jun 2020 Jun 2021 Jun 2022 Mar 2024 Mar 2025 Mar 2026
Income detail
Research and development expense (CAD) 1.68M 14.8M 26.1M 11.4M 10.4M 3.57M 3.68M 4.02M
Reported Sep 11, 2019 Sep 11, 2019 Sep 25, 2020 Sep 27, 2021 Sep 21, 2022 Jun 20, 2024 Jun 18, 2025 Jun 11, 2026

Sign up to see institutional holdings

Sign Up

Podcast Mentions

Sign up to see podcast mentions and sentiment

Sign Up

To: All Canadian Securities Regulatory Authorities Bull 0 Bear 0 Routine

Subject: AURORA CANNABIS INC.

We advise of the following with respect to the upcoming Meeting of Security Holders for the subject Issuer:

Meeting Type : Special Meeting

Record Date for Notice of Meeting : November 18, 2026

Record Date for Voting (if applicable) : November 18, 2026

Beneficial Ownership Determination Date : November 18, 2026

Meeting Date : December 23, 2026

Meeting Location (if available) : Virtually Meeting

Issuer sending proxy related materials directly to NOBO: No

Issuer paying for delivery to OBO: Yes

Notice and Access (NAA) Requirements:

NAA for Beneficial Holders No

NAA for Registered Holders No

Voting Security Details:

Description CUSIP Number ISIN

COMMON CLASS 05156X850 CA05156X8504

Sincerely,

Computershare

Agent for AURORA CANNABIS INC.

Aurora Cannabis Announces Fiscal 2027 Second Quarter Results Bull 9 Bear 0 Takeover offer

· Delivers Net Revenue of $86.0 million, including Record International Medical Cannabis Net Revenue of $61.4 million, representing a 44% YoY Increase

· Generated Adjusted EBITDA1 of $14.0 million, with Free Cash Flow1 Outflow Improving by $22.4 million

· Maintains Strong Balance Sheet with $133.0 million of Cash, Cash Equivalents2 and Short-Term Investments with no Debt

EDMONTON, AB – November 5, 2026 – Aurora Cannabis Inc. (the “Company” or “Aurora”) (NASDAQ | TSX: ACB), a leading Canada-based global medical cannabis company, today announced its financial and operational results for the second quarter 2027 ending September 30, 2026.

Aurora has cancelled its investor call, originally scheduled for November 12, 2026, at 8:00 a.m. Eastern Time | 6:00 a.m. Mountain Time, due to the Company’s announcement on November 3, 2026, that Aurora has entered into a definitive agreement (the “Arrangement Agreement”) with Organigram Global Inc. (“Organigram”) pursuant to which Organigram will acquire all of the issued and outstanding common shares of Aurora (the “Aurora Shares”).

Form of Agreement Bull 0 Bear 0 Routine

VOTING AND SUPPORT AGREEMENT

THIS AGREEMENT is made as of the 2nd day of November, 2026.

BETWEEN:

[●]

- and -

WHEREAS the Securityholder is the registered holder and/or beneficial owner of, or exercises control or direction over, the number of securities set forth on the Securityholder’s signature page of this Agreement (the “Subject Securities”);

AND WHEREAS the Organigram Global Inc. (the “Purchaser”) and Aurora have entered into an arrangement agreement (as may be amended from time to time, the “Arrangement Agreement”) concurrently with the entering into of this Agreement and propose to consummate an arrangement as set forth in the plan of arrangement attached to the Arrangement Agreement (the “Arrangement”);

AND WHEREAS the Securityholder acknowledges that Aurora would not enter into the Arrangement Agreement or complete the transactions contemplated thereby, but for the execution and delivery of this Agreement (and on the terms and conditions herein contained) by the Securityholder;

AND WHEREAS all capitalized terms used but not otherwise defined in this voting and support agreement (this “Agreement”) shall have the respective meanings ascribed to them in the Arrangeme

Prompts

Aurora Cannabis Inc. (ticker ACB), listed in United States.

ETFs Holding Aurora Cannabis Inc.

ETF Weight in ETF Shares Market value As of
YOLO 7.18% 439,135 $ 1.985M Nov 17, 2026
DFIC 0.00% 7,125 $ 35.554K Nov 12, 2026

Securities

Ticker Type Class Market Exchange Last price Price date
ACB canonical Common share — US nasdaq 3.90 USD 2026-09-30
ACB Common share — CA tsx — —